tirzepatide v Semaglutide vs for Weight Loss Compounded tirzepatide telehealth from Fitish RX Tirzepatide Dosing: Diabetes vs Weight

Multi-indication label expansion: Semaglutide approved across obesity, cardiovascular risk reduction, MASH, and sleep apnea creates a total addressable patient population of approximately 640 million globally nearly four times the obesity-only base adding new prescriber populations including cardiologists, hepatologists, and sleep medicine specialists

Monti DA, Newberg AB, Forehand V, et al

Timing relative to exercise shows no strong clinical interaction, so injecting before or after workouts does not meaningfully change semaglutide's metabolic effects

In this time, watch out for side effects that may still be there and try to eat a balanced diet